Literature DB >> 23744293

Age-related macular degeneration, anti-VEGF therapy, and ophthalmic imaging: is there a best practice?

Dennis P Han1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23744293     DOI： 10.1001/jamaophthalmol.2013.432

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  3 in total

1.  Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration: how to alleviate the clinical burden with maintained functional results.

Authors:  C Gianniou; A Dirani; W Ferrini; L Marchionno; D Decugis; A Deli; A Ambresin; I Mantel
Journal:  Eye (Lond)       Date:  2014-11-07       Impact factor: 3.775

2.  Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.

Authors:  Francesco Parmeggiani; Carla Enrica Gallenga; Ciro Costagliola; Francesco Semeraro; Mario R Romano; Roberto Dell'Omo; Andrea Russo; Katia De Nadai; Donato Gemmati; Sergio D'Angelo; Elena Bolletta; Francesco Saverio Sorrentino
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

3.  Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen.

Authors:  Irmela Mantel; Sophie-Alexia Niderprim; Christina Gianniou; Angeliki Deli; Aude Ambresin
Journal:  Br J Ophthalmol       Date:  2014-04-10       Impact factor: 4.638
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.